13th Orphan Drugs & Rare Diseases Global Congress 2020 Americas - East
17th November 2020 - Pre-Conference Workshop
18th - 19th November - 2 Days Conference
Boston, MA, USA
Hilton Boston Back Bay
40 Dalton St, Boston, MA 02115
Pharma Conference US Boston
Orphan Drugs & Rare Diseases
Paradigm Global Events is again proud to present our Orphan Drugs and Rare Diseases Global Congress 2020 Americas. It’s the 13th in the series of our Flagship tri-annual Orphan Drugs & Rare Diseases event. Due to the pandemic, we are looking to host a HYBRID Event, still the same congress but with a different set-up. This congress will provide you with a comprehensive overview of the critical issues shaping the future of Orphan Drugs.
The COVID-19 Pandemic has impacted the lives of just about everyone, patients receiving continuous treatment and care included. The Rare Disease community is already experiencing considerable challenges in achieving early and detailed diagnosis and having access to care and life-saving treatment, to chronic, highly complex, progressive and severely disabling nature of their diseases, which generate specific care needs. Undoubtedly, during this crisis, the rare diseases community is experiencing unprecedented overall disruption even more….
Featuring Key Industry Experts
From a patient advocacy organization perspective, was a very informative meeting. Learned a lot from presentations and networking that will inform how we can add value to the advocacy-patient-drug developer dialogue.
Scientific Director, Research, Association for Frontotemporal Degeneration
I was very impressed with the format, the content was interesting and well done. I felt I learned a lot and was glad to be able to attend.
Business Development at Pharm-Olam, LLC
2020 CONFERENCE FORMAT
The two-day Congress will provide an interactive, cutting edge and comprehensive discussion and networking format led by key experts with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies and concepts surrounding orphan drugs and rare diseases.